Skip to main content
    E

    Elevance Health Inc (ELV)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $446.42
    +16.73 (+3.89%)

    Market Cap: $92.84B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Elevance Health Inc (ELV) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Elevance Health (ELV) trades at 14.7x trailing earnings and 0.5x sales. Its P/E of 14.7x is above its 5-year median of 14.4x. Its forward P/E is 14.3x. The median P/E across 12 similar companies is 29.2x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 2.8% higher over the next year. Its free cash flow yield is 6.8%.

    MultipleValue
    P/E (trailing)14.7x
    Forward P/E14.3x
    Price to sales0.5x
    Price to book2.2x
    EV/EBITDA12.7x
    Price to FCF14.8x
    EV/FCF17.9x
    PEG1.3
    FCF yield6.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 2.6% below 15.1x, its P/S is 28.6% below 0.7x and its P/B is 4.3% below 2.3x.

    MultipleCurrent5-year median10-year median
    P/E14.7x14.4x15.1x
    P/S0.5x0.7x0.7x
    P/B2.2x2.8x2.3x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 11.2x in 2024 to 18.8x in 2017.

    Year endPriceP/EP/SP/B
    2025$350.5511.6x0.4x1.8x
    2024$368.9011.2x0.5x2.1x
    2023$471.5614.2x0.6x2.8x
    2022$512.9717.7x0.8x3.4x
    2021$463.5417.8x0.8x3.2x
    2020$321.0914.3x0.7x2.4x
    2019$302.0315.6x0.7x2.5x
    2018$262.6316.5x0.7x2.4x
    2017$225.0118.8x0.7x2.2x
    2016$143.7713.1x0.4x1.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ELV

    What is ELV's forward P/E ratio?

    Elevance Health has a forward P/E ratio of 14.3x.

    Is ELV stock overvalued?

    GNG's valuation label for ELV is Fairly valued. Its P/E of 14.7x compares with a median of 29.2x across 12 similar companies.

    What is ELV's price to sales ratio?

    Elevance Health has a price to sales ratio of 0.5x.

    What is Elevance Health's average P/E ratio over 5 years?

    Elevance Health's median P/E over the last 5 years is 14.4x, from 60 month-end values through Oct 2026.

    What is ELV's PEG ratio?

    Elevance Health has a PEG ratio of 1.3.